Kawasaki disease natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
| (14 intermediate revisions by 3 users not shown) | |||
| Line 2: | Line 2: | ||
{{Kawasaki disease}} | {{Kawasaki disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{SH}} | ||
==Overview== | ==Overview== | ||
If left untreated, [ | If left untreated, the [[Symptom|symptoms]] will eventually relent, but [[Coronary artery aneurysm|coronary artery aneurysms]] will not improve, resulting in a significant risk of death or disability due to [[ST elevation myocardial infarction|myocardial infarction]]. If treated in a timely fashion, this risk can be mostly avoided and the course of illness cut short. [[Patient|Patients]] with Kawasaki disease may progress to develop long term [[Cardiovascular disease|cardiovascular]] illness such as [[Coronary heart disease|coronary artery disease]], and pre-mature [[atherosclerosis]]. Common [[Complication (medicine)|complications]] of Kawasaki disease include [[vasculitis]] and [[Aneurysm|coronary artery aneurysms]]. [[Prognosis]] is generally excellent and the mortality rate of [[Patient|patients]] with Kawasaki disease is approximately 2%. | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
===Natural History=== | ===Natural History=== | ||
* If left untreated, the [[Symptom|symptoms]] will eventually relent, but [[Coronary artery aneurysm|coronary artery aneurysms]] will not improve, resulting in a significant risk of death or disability due to [[ST elevation myocardial infarction|myocardial infarction]]. | |||
* If treated in a timely fashion, this risk can be mostly avoided and the course of illness cut short. | |||
*[[Patient|Patients]] with Kawasaki disease may progress to develop long term [[Cardiovascular disease|cardiovascular]] illness such as [[Coronary heart disease|coronary artery disease]], and pre-mature [[atherosclerosis]].<ref name="pmid255183982">{{cite journal |vauthors=Kato H |title=[Natural history of Kawasaki disease vasculitis] |language=Japanese |journal=Nippon Rinsho |volume=72 |issue=9 |pages=1530–5 |date=September 2014 |pmid=25518398 |doi= |url=}}</ref> | |||
===Complications=== | ===Complications=== | ||
The [[cardiac]] complications are, by far, the most important aspect of | * The [[cardiac]] complications are, by far, the most important aspect of Kawasaki disease:<ref>{{cite journal | author = Belay E, Maddox R, Holman R, Curns A, Ballah K, Schonberger L | title = Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. | journal = Pediatr Infect Dis J | volume = 25 | issue = 3 | pages = 245-9 | year = 2006 | id = PMID 16511388}}</ref><ref name="McCrindleRowley2017">{{cite journal|last1=McCrindle|first1=Brian W.|last2=Rowley|first2=Anne H.|last3=Newburger|first3=Jane W.|last4=Burns|first4=Jane C.|last5=Bolger|first5=Anne F.|last6=Gewitz|first6=Michael|last7=Baker|first7=Annette L.|last8=Jackson|first8=Mary Anne|last9=Takahashi|first9=Masato|last10=Shah|first10=Pinak B.|last11=Kobayashi|first11=Tohru|last12=Wu|first12=Mei-Hwan|last13=Saji|first13=Tsutomu T.|last14=Pahl|first14=Elfriede|title=Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association|journal=Circulation|volume=135|issue=17|year=2017|pages=e927–e999|issn=0009-7322|doi=10.1161/CIR.0000000000000484}}</ref> | ||
* | ** Vasculitic changes in the [[coronary arteries]] | ||
* [[Coronary artery aneurysm|Coronary artery aneurysms]] | **[[Coronary artery aneurysm|Coronary artery aneurysms]] | ||
** These [[Aneurysm|aneurysms]] can lead to [[myocardial infarction]] even in young children. Overall, about 10 | *** These [[Aneurysm|aneurysms]] can lead to [[myocardial infarction]] even in young children. Overall, about 10 - 18% of children with Kawasaki disease develop [[Coronary artery aneurysm|coronary artery aneurysms]], with much higher [[prevalence]] among [[Patient|patients]] who are not treated early in the course of [[illness]]. | ||
*** Kawasaki disease is the most common cause of acquired [[heart disease]] among children in the United States. | |||
<ref name="pmid41111">{{cite journal |vauthors=Amano S, Hazama F, Hamashima Y |title=Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes |journal=Jpn. Circ. J. |volume=43 |issue=7 |pages=633–43 |date=July 1979 |pmid=41111 |doi= |url=}}</ref> | * Other [[complications]] associated with Kawasaki disease are: <ref name="pmid41111">{{cite journal |vauthors=Amano S, Hazama F, Hamashima Y |title=Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes |journal=Jpn. Circ. J. |volume=43 |issue=7 |pages=633–43 |date=July 1979 |pmid=41111 |doi= |url=}}</ref> | ||
{| | {| | ||
! style="background:#4479BA; color: #FFFFFF;" |Organ and Tissue | ! style="background:#4479BA; color: #FFFFFF;" |Organ and Tissue | ||
! style="background:#4479BA; color: #FFFFFF;" |Associated | ! style="background:#4479BA; color: #FFFFFF;" |Associated Conditions | ||
|- | |- | ||
! style="background:#DCDCDC;" |[[Liver]] | |||
| style="background:#DCDCDC;" | [[Hepatitis]] | | style="background:#DCDCDC;" | | ||
* [[Hepatitis]] | |||
|- | |- | ||
! style="background:#DCDCDC;" |[[Lung]] | |||
| style="background:#DCDCDC;" | [[Interstitial pneumonitis]] | | style="background:#DCDCDC;" | | ||
* [[Interstitial pneumonitis]] | |||
|- | |- | ||
! style="background:#DCDCDC;" |[[Gastrointestinal tract]] | |||
| style="background:#DCDCDC;" | [[Abdominal pain]] | | style="background:#DCDCDC;" | | ||
[[Diarrhea]] | * [[Abdominal pain]] | ||
* [[Diarrhea]] | |||
[[Vomiting]] | * [[Vomiting]] | ||
* [[Gallbladder]] hydrops | |||
[[Gallbladder]] hydrops | |||
|- | |- | ||
! style="background:#DCDCDC;" |[[Meninges]] | |||
| style="background:#DCDCDC;" | [[Aseptic meningitis]] | | style="background:#DCDCDC;" | | ||
[[Irritability]] | * [[Aseptic meningitis]] | ||
* [[Irritability]] | |||
|- | |- | ||
! style="background:#DCDCDC;" |[[Heart]] | |||
| style="background:#DCDCDC;" | [[Myocarditis]] | | style="background:#DCDCDC;" | | ||
[[Pericarditis]] | * [[Myocarditis]] | ||
* [[Pericarditis]] | |||
[[Valvulitis]] | * [[Valvulitis]] | ||
|- | |- | ||
! style="background:#DCDCDC;" |[[Urinary tract]] | |||
| style="background:#DCDCDC;" | [[Pyuria]] | | style="background:#DCDCDC;" | | ||
* [[Pyuria]] | |||
|- | |- | ||
! style="background:#DCDCDC;" |[[Pancreas]] | |||
| style="background:#DCDCDC;" | [[Pancreatitis]] | | style="background:#DCDCDC;" | | ||
* [[Pancreatitis]] | |||
|- | |- | ||
! style="background:#DCDCDC;" |[[Lymph node|Lymph nodes]] | |||
| style="background:#DCDCDC;" | [[Lymphadenopathy]] | | style="background:#DCDCDC;" | | ||
* [[Lymphadenopathy]] | |||
|} | |} | ||
===Prognosis=== | ===Prognosis=== | ||
* With early treatment, rapid recovery from the acute symptoms can be expected and the risk of coronary artery aneurysms greatly reduced. Untreated, the acute symptoms of Kawasaki disease are self-limited, but the risk of coronary artery involvement is much greater. | * With early treatment, rapid recovery from the acute [[Symptom|symptoms]] can be expected and the risk of [[Coronary artery aneurysm|coronary artery aneurysms]] greatly reduced. | ||
* | *Untreated, the acute [[Symptom|symptoms]] of Kawasaki disease are self-limited, but the risk of [[Coronary arteries|coronary artery]] involvement is much greater. | ||
*[[Patient|Patients]] who have had Kawasaki disease should have an [[echocardiogram]] initially every few weeks, and then every 1 - 2 years to [[Screening (medicine)|screen]] for the progression of [[Heart|cardiac]] involvement. | |||
* Overall, about 2% of the [[Patient|patients]] die from [[Complication (medicine)|complications]] of [[coronary]] [[vasculitis]]. | |||
* It is also not uncommon that a [[relapse]] of symptoms may occur soon after initial treatment with [[IVIG]]. | * It is also not uncommon that a [[relapse]] of symptoms may occur soon after initial treatment with [[IVIG]]. | ||
** This usually requires re-hospitalization and retreatment. Treatment with [[IVIG]] can cause allergic and non-allergic acute reactions, [[aseptic meningitis]], [[fluid overload]] and rarely other serious reactions. | ** This usually requires re-hospitalization and retreatment. Treatment with [[IVIG]] can cause allergic and non-allergic acute reactions, [[aseptic meningitis]], [[fluid overload]] and rarely other serious reactions. | ||
| Line 76: | Line 79: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Pediatrics]] | ||
[[Category:Cardiovascular diseases]] | |||
[[Category:Angiology]] | |||
[[Category:Cardiology]] | |||
[[Category:Rheumatology]] | |||
[[Category:Dermatology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Up-To-Date]] | |||
Latest revision as of 16:52, 14 February 2020
|
Kawasaki disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
American Roentgen Ray Society Images of Kawasaki disease natural history, complications and prognosis |
|
FDA on Kawasaki disease natural history, complications and prognosis |
|
CDC on Kawasaki disease natural history, complications and prognosis |
|
Kawasaki disease natural history, complications and prognosis in the news |
|
Blogs on Kawasaki disease natural history, complications and prognosis |
|
Risk calculators and risk factors for Kawasaki disease natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
If left untreated, the symptoms will eventually relent, but coronary artery aneurysms will not improve, resulting in a significant risk of death or disability due to myocardial infarction. If treated in a timely fashion, this risk can be mostly avoided and the course of illness cut short. Patients with Kawasaki disease may progress to develop long term cardiovascular illness such as coronary artery disease, and pre-mature atherosclerosis. Common complications of Kawasaki disease include vasculitis and coronary artery aneurysms. Prognosis is generally excellent and the mortality rate of patients with Kawasaki disease is approximately 2%.
Natural History, Complications, and Prognosis
Natural History
- If left untreated, the symptoms will eventually relent, but coronary artery aneurysms will not improve, resulting in a significant risk of death or disability due to myocardial infarction.
- If treated in a timely fashion, this risk can be mostly avoided and the course of illness cut short.
- Patients with Kawasaki disease may progress to develop long term cardiovascular illness such as coronary artery disease, and pre-mature atherosclerosis.[1]
Complications
- The cardiac complications are, by far, the most important aspect of Kawasaki disease:[2][3]
- Vasculitic changes in the coronary arteries
- Coronary artery aneurysms
- These aneurysms can lead to myocardial infarction even in young children. Overall, about 10 - 18% of children with Kawasaki disease develop coronary artery aneurysms, with much higher prevalence among patients who are not treated early in the course of illness.
- Kawasaki disease is the most common cause of acquired heart disease among children in the United States.
- Other complications associated with Kawasaki disease are: [4]
| Organ and Tissue | Associated Conditions |
|---|---|
| Liver | |
| Lung | |
| Gastrointestinal tract |
|
| Meninges | |
| Heart | |
| Urinary tract | |
| Pancreas | |
| Lymph nodes |
Prognosis
- With early treatment, rapid recovery from the acute symptoms can be expected and the risk of coronary artery aneurysms greatly reduced.
- Untreated, the acute symptoms of Kawasaki disease are self-limited, but the risk of coronary artery involvement is much greater.
- Patients who have had Kawasaki disease should have an echocardiogram initially every few weeks, and then every 1 - 2 years to screen for the progression of cardiac involvement.
- Overall, about 2% of the patients die from complications of coronary vasculitis.
- It is also not uncommon that a relapse of symptoms may occur soon after initial treatment with IVIG.
- This usually requires re-hospitalization and retreatment. Treatment with IVIG can cause allergic and non-allergic acute reactions, aseptic meningitis, fluid overload and rarely other serious reactions.
- Aspirin may increase the risk of bleeding from other causes and may be associated with Reye's syndrome.
- Overall, life-threatening complications resulting from therapy for Kawasaki disease are exceedingly rare, especially compared with the risk of non-treatment.
References
- ↑ Kato H (September 2014). "[Natural history of Kawasaki disease vasculitis]". Nippon Rinsho (in Japanese). 72 (9): 1530–5. PMID 25518398.
- ↑ Belay E, Maddox R, Holman R, Curns A, Ballah K, Schonberger L (2006). "Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003". Pediatr Infect Dis J. 25 (3): 245–9. PMID 16511388.
- ↑ McCrindle, Brian W.; Rowley, Anne H.; Newburger, Jane W.; Burns, Jane C.; Bolger, Anne F.; Gewitz, Michael; Baker, Annette L.; Jackson, Mary Anne; Takahashi, Masato; Shah, Pinak B.; Kobayashi, Tohru; Wu, Mei-Hwan; Saji, Tsutomu T.; Pahl, Elfriede (2017). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association". Circulation. 135 (17): e927–e999. doi:10.1161/CIR.0000000000000484. ISSN 0009-7322.
- ↑ Amano S, Hazama F, Hamashima Y (July 1979). "Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes". Jpn. Circ. J. 43 (7): 633–43. PMID 41111.